IDEXX Laboratories, Inc.
IDXXLast close · Oct 16, 2026560.36+13.18 (+2.41%)
Market cap$44.1B
Key indicators
Revenue4.6B+12.8% on a year earlier
2.2B
2.4B
2.7B
3.2B
3.4B
3.7B
3.9B
4.3B
4.6B
4.7B
5.1B
5.6B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 2.2B | 2.4B+8.8% | 2.7B+12.5% | 3.2B+18.8% | 3.4B+4.7% | 3.7B+8.7% | 3.9B+6.5% | 4.3B+10.4% | 4.6B+12.8% | 4.7B | 5.1B | 5.6B | |
| — | 8.8% | 12.5% | 18.8% | 4.7% | 8.7% | 6.5% | 10.4% | 12.8% | 9.7% | 8.9% | 9.2% | |
| $4.26 | $4.89+14.8% | $6.71+37.2% | $8.60+28.2% | $8.03−6.6% | $10.06+25.3% | $10.67+6.1% | $13.08+22.6% | $14.23+18.5% | $14.76 | $16.75 | $19.04 | |
| Profitability | ||||||||||||
| 56.1% | 56.7%+0.6 pt | 58.0%+1.3 pt | 58.8%+0.7 pt | 59.5%+0.8 pt | 59.8%+0.3 pt | 61.0%+1.2 pt | 61.8%+0.8 pt | 62.4%+0.9 pt | · | · | · | |
| 22.2% | 23.0%+0.8 pt | 25.7%+2.7 pt | 29.0%+3.3 pt | 26.7%−2.3 pt | 30.0%+3.3 pt | 29.0%−1.0 pt | 31.6%+2.7 pt | 32.0%+0.9 pt | · | · | · | |
| 17.0% | 17.8%+0.7 pt | 21.5%+3.7 pt | 23.2%+1.7 pt | 20.2%−3.0 pt | 23.1%+2.9 pt | 22.8%−0.3 pt | 24.6%+1.8 pt | 25.0%+0.6 pt | · | · | · | |
| -3963.3% | 241.0%+4204.3 pt | 92.0%−149.0 pt | 107.9%+15.9 pt | 111.6%+3.6 pt | 56.9%−54.6 pt | 55.7%−1.3 pt | 66.0%+10.3 pt | — | · | · | · | |
| Cash | ||||||||||||
| 284.3M | 304.2M+7.0% | 541.1M+77.9% | 636.0M+17.5% | 394.1M−38.0% | 772.9M+96.1% | 808.1M+4.6% | 1.1B+30.8% | 1.3B+59.9% | · | · | · | |
| 12.8% | 12.6%−0.2 pt | 20.0%+7.4 pt | 19.8%−0.2 pt | 11.7%−8.1 pt | 21.1%+9.4 pt | 20.7%−0.4 pt | 24.6%+3.8 pt | 27.5%+8.1 pt | · | · | · | |
| Balance sheet | ||||||||||||
| -63.26x | 3.94x+67.20x | 1.44x−2.50x | 1.23x−0.21x | 1.26x+0.03x | 0.47x−0.79x | 0.39x−0.08x | 0.28x−0.11x | 0.28x−0.08x | · | · | · | |
| 88.47M | 87.54M−1.0% | 86.72M−0.9% | 86.57M−0.2% | 84.60M−2.3% | 83.98M−0.7% | 83.25M−0.9% | 81.03M−2.7% | 79.31M−2.1% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.